AR049195A1 - Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento - Google Patents
Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamentoInfo
- Publication number
- AR049195A1 AR049195A1 ARP050102211A ARP050102211A AR049195A1 AR 049195 A1 AR049195 A1 AR 049195A1 AR P050102211 A ARP050102211 A AR P050102211A AR P050102211 A ARP050102211 A AR P050102211A AR 049195 A1 AR049195 A1 AR 049195A1
- Authority
- AR
- Argentina
- Prior art keywords
- ethinylestradiol
- combination
- preparation
- clormadinone
- acetate
- Prior art date
Links
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 title abstract 3
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 title abstract 3
- 229960002568 ethinylestradiol Drugs 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title 1
- VUHJZBBCZGVNDZ-TTYLFXKOSA-N chlormadinone Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 VUHJZBBCZGVNDZ-TTYLFXKOSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 abstract 2
- 229960001616 chlormadinone acetate Drugs 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000027758 ovulation cycle Effects 0.000 abstract 2
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002657 hormone replacement therapy Methods 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparcion de un medicamento que se usa en mujeres para el tratamiento simultáneo de: trastornos inducidos por androgenos y para la terapia de sustitucion hormonal y para el tratamiento de la dismenorrea y para la estabilizacion del ciclo menstrual y para el tratamiento de trastornos dependientes del ciclo menstrual y para la contracepcion. Reivindicacion 3: Uso segun la reivindicacion 1 o 2, caracterizado porque la combinacion comprende 5 a 50 microgramos de etinilestradiol y 1 a 5 mg de acetato de clormadinona por unidad diaria.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004026669A DE102004026669A1 (de) | 2004-05-28 | 2004-05-28 | Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049195A1 true AR049195A1 (es) | 2006-07-05 |
Family
ID=34982562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102211A AR049195A1 (es) | 2004-05-28 | 2005-05-27 | Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050267081A1 (es) |
| EP (1) | EP1753435A1 (es) |
| AR (1) | AR049195A1 (es) |
| AU (1) | AU2005247101B2 (es) |
| BR (1) | BRPI0511864A (es) |
| DE (1) | DE102004026669A1 (es) |
| EC (1) | ECSP067030A (es) |
| MX (1) | MXPA06013800A (es) |
| PE (1) | PE20060402A1 (es) |
| RU (1) | RU2394579C2 (es) |
| WO (1) | WO2005115402A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004026671A1 (de) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Darreichungsform zur hormonalen Kontrazeption |
| DE102006003508A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Arzneimittel umfassend eine Hormonkombination |
| DE102006003509A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Kontrazeptivum |
| DE102006062119A1 (de) * | 2006-12-22 | 2008-06-26 | Grünenthal GmbH | Arzneimittel zur Behandlung von Hauterkrankungen |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| AU4805085A (en) * | 1984-09-05 | 1986-03-24 | Schering Aktiengesellschaft | Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels |
| DE3916112A1 (de) * | 1989-05-16 | 1990-11-22 | Schering Ag | Dihydrospirorenon als antiandrogen |
| DE4104385C1 (es) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich | |
| US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
| DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
| US6511970B1 (en) * | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
| DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| US6326392B1 (en) * | 1997-11-06 | 2001-12-04 | American Home Products Corporation | Anti-estrogen plus progestin containing oral contraceptives |
| CN1644201A (zh) * | 1998-04-17 | 2005-07-27 | 奥索-麦克尼尔药品公司 | 含有叶酸的药用组合物的用途 |
| US6265393B1 (en) * | 1998-08-07 | 2001-07-24 | Heinrichs William Leroy | Prevention of endometriosis signs or symptons |
| NZ534348A (en) * | 2000-01-28 | 2006-06-30 | Endorech Inc | Selective estrogen receptor modulators in combination with estrogens |
| DE10045380A1 (de) * | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
| PT1390040E (pt) * | 2001-05-18 | 2007-04-30 | Pantarhei Bioscience Bv | Composição farmacêutica para ser utilizado na terapia hormonal de substituição. |
| CA2494687A1 (en) * | 2002-08-15 | 2004-02-26 | Wyeth | Agonism of the 5ht2a receptor for treatment of thermoregulatory dysfunction |
| US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
-
2004
- 2004-05-28 DE DE102004026669A patent/DE102004026669A1/de not_active Withdrawn
- 2004-12-10 US US11/009,361 patent/US20050267081A1/en not_active Abandoned
-
2005
- 2005-05-27 EP EP05763426A patent/EP1753435A1/de not_active Ceased
- 2005-05-27 BR BRPI0511864-6A patent/BRPI0511864A/pt not_active Application Discontinuation
- 2005-05-27 MX MXPA06013800A patent/MXPA06013800A/es active IP Right Grant
- 2005-05-27 WO PCT/EP2005/005764 patent/WO2005115402A1/de not_active Ceased
- 2005-05-27 AR ARP050102211A patent/AR049195A1/es unknown
- 2005-05-27 RU RU2006145077/15A patent/RU2394579C2/ru active
- 2005-05-27 PE PE2005000595A patent/PE20060402A1/es not_active Application Discontinuation
- 2005-05-27 AU AU2005247101A patent/AU2005247101B2/en not_active Ceased
-
2006
- 2006-11-27 EC EC2006007030A patent/ECSP067030A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005247101A1 (en) | 2005-12-08 |
| BRPI0511864A (pt) | 2008-01-22 |
| PE20060402A1 (es) | 2006-07-12 |
| ECSP067030A (es) | 2006-12-29 |
| DE102004026669A1 (de) | 2005-12-15 |
| US20050267081A1 (en) | 2005-12-01 |
| RU2006145077A (ru) | 2008-07-10 |
| WO2005115402A1 (de) | 2005-12-08 |
| MXPA06013800A (es) | 2007-02-02 |
| AU2005247101B2 (en) | 2011-02-17 |
| RU2394579C2 (ru) | 2010-07-20 |
| EP1753435A1 (de) | 2007-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0109334A (pt) | Terapia de reposição hormonal | |
| PE20051038A1 (es) | Uso extendido de combinacion que comprende estrogenos y progestinas | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| ATE493132T1 (de) | Arzneimittel umfassend wenigstens ein gestagen | |
| JP2013514984A5 (es) | ||
| AR033042A1 (es) | Terapia de reemplazo hormonal | |
| PE20060467A1 (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| HRP20090418T1 (hr) | Farmaceutski pripravak koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
| AR054144A1 (es) | Regimenes para anticonceptivos monofasicos orales | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| PE20040068A1 (es) | Decanoato, undecanoato y dodecanoato de etonogestrel | |
| AR065816A1 (es) | Regimen anticonceptivo oral | |
| AR048106A1 (es) | Dispositivo de distribucion de drogas visible por rayos x | |
| AR049197A1 (es) | Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona | |
| AR049195A1 (es) | Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| PE20060368A1 (es) | Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| WO2003084521A3 (en) | Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy | |
| ATE395047T1 (de) | Feste perorale arzneiform zur kontrazeption, die dienogest und ethinylestradiol enthält | |
| NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
| BR0309621A (pt) | Uso de estrógenos conjugados em combinação com trimegestona na terapia de substituição de hormÈnios | |
| CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |